Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
Amway just suffered a post-earnings selloff, breaking below key averages with bearish momentum. Fundamentals show slowing growth and margin pressure, making it more of a dividend defensive stock than a growth play in the near term.
